COSUNTER Trademark

Trademark Overview


On Tuesday, September 3, 2024, a trademark application was filed for COSUNTER with the United States Patent and Trademark Office. The USPTO has given the COSUNTER trademark a serial number of 98731337. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 24, 2025. This trademark is owned by FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.. The COSUNTER trademark is filed in the Pharmaceutical Products category with the following description:

Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal preparations for human use, the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS...
cosunter

General Information


Serial Number98731337
Word MarkCOSUNTER
Filing DateTuesday, September 3, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2025

Trademark Statements


Goods and ServicesNutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal preparations for human use, the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Drugs for medical purposes, namely, medicaments for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Pharmaceutical preparations, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Crude drugs, namely, medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Biochemical medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purpose

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFujian 355300
CN

Party NameFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFujian 355300
CN

Trademark Events


Event DateEvent Description
Tuesday, September 3, 2024NEW APPLICATION ENTERED
Tuesday, September 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 6, 2025ASSIGNED TO EXAMINER
Friday, March 21, 2025NON-FINAL ACTION WRITTEN
Friday, March 21, 2025NON-FINAL ACTION E-MAILED
Friday, March 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 18, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 24, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 24, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 7, 2025ASSIGNED TO EXAMINER